Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects
CT_TKA
1 other identifier
interventional
160
1 country
1
Brief Summary
The investigators propose a randomized controlled trial to evaluate the effects of treatment intended to reduce pain catastrophizing among patients reporting high pain catastrophizing prior to total knee replacement(TKR), total hip replacement(THR), or shoulder surgery in an effort to thereby reduce the incidence of persistent post-surgical pain (PPP) and enhance physical function at 3-months post-surgery. Preemptive treatment aimed at a known predictor of PPP following total knee replacement is highly innovative and have potentially high impact for public health. Cognitive therapy is a well-tolerated modality among chronic pain patients with few if any side effects. Cognitive therapy (CT) represents an inexpensive method that could greatly reduce suffering and costly post-surgical pain management for high risk TKR patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 17, 2013
CompletedFirst Posted
Study publicly available on registry
January 21, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedJune 28, 2022
June 1, 2022
7.6 years
January 17, 2013
June 24, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
(Aim 1) Pain Catastrophizing Scale (PCS)
Pain Catastrophizing Scale - Min=0, Max=52, Higher score = more catastrophizing so lower scores are preferable.
4 or 8 weeks after start of treatment
(Aim 2) Proportion of patients with pain relief
Proportion of patients w a 3 month decrease in WOMAC pain subscale \<= 4. (WOMAC Osteoarthritis Index)
3 month
Secondary Outcomes (2)
Patient Health Questionnaire (PHQ-8)
4 and 8 weeks after start of treatment
Generalized anxiety disorder (GAD-7)
4 and 8 weeks after start of treatment
Study Arms (4)
4 weekly CT sessions - in person
EXPERIMENTAL4 weekly CT sessions; all will be 1-hr individual cognitive therapy sessions with the psychology staff (under the supervision of John Burns, PhD).
8 weekly CT sessions
EXPERIMENTAL8 weekly CT sessions; 1st and 8th will be 1-hr individual cognitive therapy session with the psychology staff (under the supervision of John Burns, PhD). The intermediate CT sessions will be by telephone call or video/"Skype". Our group will purchase and setup a web camera and headphone/microphone for the subjects in the CT groups that use "Skype". The 1-hr CT protocol was adapted from Dr. Beverly E. Thorn's CT manual (Cognitive Therapy for Chronic Pain: A Step-by-Step Guide; Thorn, 2004; with the Client and Therapy Workbooks.
4 weekly CT sessions - Tele-video
EXPERIMENTAL4 weekly CT sessions; 1st and 4th will be 1-hr individual cognitive therapy session with the psychology staff. The intermediate CT sessions will be by telephone call or video/"Skype".
Routine care
PLACEBO COMPARATORRoutine care; no CT sessions
Interventions
CT will be used as a preemptive treatment in an effort to minimize the effects of catastrophic thinking.
Eligibility Criteria
You may qualify if:
- undergoing standard primary TKR; THR or Shoulder Surgery
- yrs of age;
- Surgical joint is the primary source of patient's pain;
- Patient agrees to preoperative visits and treatment, follow-up visits and treatment, and to comply with the assessment tests;
- Patient consents to standard anesthetic and analgesic protocol, with medical care as deemed necessary by the anesthesiologist, and has no contraindications.
- Patient has been diagnosed with osteoarthritis.
You may not qualify if:
- Currently using antidepressant medication or undergoing cognitive therapy;
- chronic opioid use ≥ 10 mg/day of morphine equivalents within one wk prior to the surgery, and duration of use \> 4 wks;
- history of opioid abuse;
- inability to understand and communicate with the investigators to complete the study related questionnaires
- patient is planning to undergo another elective joint procedure during the 6-mo period of participation;
- any co-morbidity which results in severe systemic disease limiting function {as defined by the American Society of Anesthesiology (ASA) physical status classification \> 3}.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rush University Medical Centerlead
- Pfizercollaborator
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
Related Publications (1)
Buvanendran A, Sremac AC, Merriman PA, Della Valle CJ, Burns JW, McCarthy RJ. Preoperative cognitive-behavioral therapy for reducing pain catastrophizing and improving pain outcomes after total knee replacement: a randomized clinical trial. Reg Anesth Pain Med. 2021 Apr;46(4):313-321. doi: 10.1136/rapm-2020-102258. Epub 2021 Jan 15.
PMID: 33452201DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asokumar Buvanendran, MD
Rush UMC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Profesor Anesthesiology
Study Record Dates
First Submitted
January 17, 2013
First Posted
January 21, 2013
Study Start
January 1, 2013
Primary Completion
August 1, 2020
Study Completion
October 1, 2020
Last Updated
June 28, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share
No plan to share data as of yet but may be willing to.